Glaucoma cure drug detained in the Alcon Lab
Recently the Eye-care giant Alcon Laboratories is shelving a long-studied drug that initially had been considered promising for treating age-related macular degeneration and glaucoma.
Recently the Eye-care giant Alcon Laboratories is shelving a long-studied drug that initially had been considered promising for treating age-related macular degeneration and glaucoma.
WASHINGTON - Older adults with low cognitive function are more likely to have the early stages of age-related macular degeneration, a new study has found.
The world’s first stem cell therapy to cure the most common cause of blindness has been developed by British researchers.
NT-501, the lead product candidate of Neurotech Pharmaceutisals, inc., have successfully slowed down the loss of vision in a Phase 2 clinical trial, in patients suffering from macular degeneration along with geographic atrophy(GA). GA is a condition that destroys sharp central vision and causes serious vision loss to one or both eyes.
Do you know what is gene mutation and what havoc it can create? A gene mutation is a permanent change in the DNA sequence that makes up a gene. Mutations range in size from a single DNA building block (DNA base) to a large segment of a chromosome. The changes can result in various disorders of incurable types.